Biomedical researchers often ask what the best antibody is for their target. "The answer depends on a multitude of factors, from application and platform to the sample type being investigated," says ...
Verywell Health on MSN
Understanding the ANA blood test (antinuclear antibody test)
Medically reviewed by Anita C. Chandrasekaran, MD Key Takeaways An ANA blood test is used to find antinuclear antibodies that can be linked to autoimmune diseases.The test shows a positive result if ...
Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, and La Jolla Institute for Immunology (LJI), a globally recognized non-profit research organization ...
Since the successful production of humanized antibodies in the 1980s, antibody-based medications have become increasingly essential in clinical treatment, taking advantage of their low immunogenicity ...
Determining the specificity of HLA antibodies is arguably one of the most important contributions by the HLA laboratory today. For patients that have low-to-moderate levels of antibody, using a ...
Monoclonal antibodies (mAbs) bind to a variety of targets with high affinity and specificity, making them ideal therapeutics. However, traditional approaches to antibody screening workflows are labor ...
A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...
A novel biomarker derived from Epstein-Barr virus (EBV) significantly improved the diagnostic accuracy for nasopharyngeal carcinoma, a large screening study from China showed. Screening with P85-Ab, ...
Antibody discovery research paves the way for new therapeutics. The search for the right antibody for a specific therapeutic application necessitates several iterations of antibody production and ...
Antibody tests weren't meant to gauge COVID-19 vaccine immunity. Dr. Anthony Fauci said they also wouldn't be the best sign you need a booster.
R&D software developer Dotmatics is rolling out a platform for discovering and developing therapeutic antibodies and proteins. It’s the first part of what the company describes will grow to become a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results